At Vixen Bio, we empower the world of antibodies - therapeutics and diagnostics - with cutting-edge bioanalytical services tailored for the pharmaceutical and clinical development sectors. We derisk development and clinical trials early by fast, custom measurements in clinically relevant conditions.
With deep expertise in immunology and advanced analytics, we specialize in supporting faster, more informed, and safer drug and diagnostic development. Our mission is to help CRO’s, pharma and biotech companies accelerate innovation—from discovery through clinical trials—by delivering precise, immune response–driven insights that inform better design, production, dosing, earlier detection of adverse effects, and more personalized treatment strategies.
We’re not just a service provider—we’re a partner in innovation. Whether it's navigating complex biologics design or optimizing clinical trial outcomes, Vixen Bio is committed to making precision medicine a reality.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Bollebergen 2b, Second Floor,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.vixenbio.com
- HQ
- Ghent, Flemish Region
Vixen Bio Questions
Vixen Bio's website is http://www.vixenbio.com
Vixen Bio's LinkedIn profile is https://be.linkedin.com/company/vixenbio
Vixen Bio has
8 employees.
View email and phone details for 8
employees at Vixen Bio.
Vixen Bio's industry is
Biotechnology Research
Vixen Bio's top competitors are
Sunbird Medical Devices,
Legend Biotech,
Biomaric Nv,
Argenx,
Neuroventis (Helpilepsy & Migrainemanager),
Antelope Dx,
Thrive Bioscience, Inc.,
Nucomat, Your Partner In Lab Automation,
Meep,
Aptamer Group.
Vixen Bio's categories are Biotechnology Research
Vixen Bio's founding year is 2025
